老年髋部骨折患者围手术期使用美沙酮的可行性:持续再评估试验(MetaHip 试验)

Kevin Heebøll Nygaard , Lasse Eriksen , Thomas Strøm , Kirsten Specht , Sofie Ronja Petersen , Jesper Ougaard Schønnemann
{"title":"老年髋部骨折患者围手术期使用美沙酮的可行性:持续再评估试验(MetaHip 试验)","authors":"Kevin Heebøll Nygaard ,&nbsp;Lasse Eriksen ,&nbsp;Thomas Strøm ,&nbsp;Kirsten Specht ,&nbsp;Sofie Ronja Petersen ,&nbsp;Jesper Ougaard Schønnemann","doi":"10.1016/j.jorep.2024.100475","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Hip fractures cause extreme pain, primarily affecting the older and frail. The necessity of sufficient pain relief in combination with a lower tolerance for drugs makes the analgesic treatment of older patients difficult. A single dose of methadone might reduce postoperative pain and opioid consumption. However, the safety of using methadone for older and fragile patients is unknown.</div></div><div><h3>Aim</h3><div>Determine the maximal tolerable dose (MTD) of perioperative methadone in older hip fracture patients and assess the feasibility of this protocol for future clinical trials.</div></div><div><h3>Methods</h3><div>Hip fracture patients ≥60 years old were consecutively included at the hospital in the winter/spring of 2023. An adaptive algorithm allocated 0.10 mg/kg, 0.15 mg/kg, or 0.20 mg/kg of methadone to each patient, administered intravenously at the induction of anesthesia. The primary outcome was respiratory depression, which was monitored continuously. Occurrence required a dosage decrease, while absence allowed an increase. Registered Nurses at the orthopedic ward collected data using observation charts completed 6, 24, and 72 hours after surgery. Secondary outcomes include time spent in the post-anesthesia care unit (PACU), verbal rating pain score (VRS), opioid consumption, and nausea/vomiting.</div></div><div><h3>Results</h3><div>30 patients completed the study. Nine received 0.10 mg/kg, and 21 received 0.15 mg/kg. Three patients experienced respiratory depression in PACU, all receiving 0.15 mg/kg methadone and undergoing general anesthesia. None of the spinal anesthesia patients or those receiving 0.10 mg/kg experienced respiratory depression.</div></div><div><h3>Conclusion</h3><div>Methadone is an effective analgesic for hip fracture surgery. The data suggests that the maximal tolerable dose of methadone in older hip fracture patients is 0.10 mg/kg. This study proves the feasibility of our trial setup and provides a foundation for future randomized controlled trials. Additionally, the findings suggest that the tolerability of methadone may vary depending on the type of anesthesia used, which merits further investigation.</div></div>","PeriodicalId":100818,"journal":{"name":"Journal of Orthopaedic Reports","volume":"4 4","pages":"Article 100475"},"PeriodicalIF":0.0000,"publicationDate":"2024-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The feasibility of perioperative methadone in older hip fracture patients: A pilot continual reassessment trial (MetaHip trial)\",\"authors\":\"Kevin Heebøll Nygaard ,&nbsp;Lasse Eriksen ,&nbsp;Thomas Strøm ,&nbsp;Kirsten Specht ,&nbsp;Sofie Ronja Petersen ,&nbsp;Jesper Ougaard Schønnemann\",\"doi\":\"10.1016/j.jorep.2024.100475\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div>Hip fractures cause extreme pain, primarily affecting the older and frail. The necessity of sufficient pain relief in combination with a lower tolerance for drugs makes the analgesic treatment of older patients difficult. A single dose of methadone might reduce postoperative pain and opioid consumption. However, the safety of using methadone for older and fragile patients is unknown.</div></div><div><h3>Aim</h3><div>Determine the maximal tolerable dose (MTD) of perioperative methadone in older hip fracture patients and assess the feasibility of this protocol for future clinical trials.</div></div><div><h3>Methods</h3><div>Hip fracture patients ≥60 years old were consecutively included at the hospital in the winter/spring of 2023. An adaptive algorithm allocated 0.10 mg/kg, 0.15 mg/kg, or 0.20 mg/kg of methadone to each patient, administered intravenously at the induction of anesthesia. The primary outcome was respiratory depression, which was monitored continuously. Occurrence required a dosage decrease, while absence allowed an increase. Registered Nurses at the orthopedic ward collected data using observation charts completed 6, 24, and 72 hours after surgery. Secondary outcomes include time spent in the post-anesthesia care unit (PACU), verbal rating pain score (VRS), opioid consumption, and nausea/vomiting.</div></div><div><h3>Results</h3><div>30 patients completed the study. Nine received 0.10 mg/kg, and 21 received 0.15 mg/kg. Three patients experienced respiratory depression in PACU, all receiving 0.15 mg/kg methadone and undergoing general anesthesia. None of the spinal anesthesia patients or those receiving 0.10 mg/kg experienced respiratory depression.</div></div><div><h3>Conclusion</h3><div>Methadone is an effective analgesic for hip fracture surgery. The data suggests that the maximal tolerable dose of methadone in older hip fracture patients is 0.10 mg/kg. This study proves the feasibility of our trial setup and provides a foundation for future randomized controlled trials. Additionally, the findings suggest that the tolerability of methadone may vary depending on the type of anesthesia used, which merits further investigation.</div></div>\",\"PeriodicalId\":100818,\"journal\":{\"name\":\"Journal of Orthopaedic Reports\",\"volume\":\"4 4\",\"pages\":\"Article 100475\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-10-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Orthopaedic Reports\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2773157X2400170X\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Orthopaedic Reports","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2773157X2400170X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

背景髋部骨折会引起剧烈疼痛,主要影响年老体弱者。由于必须充分止痛,再加上对药物的耐受性较低,因此老年患者的镇痛治疗十分困难。单剂量美沙酮可减少术后疼痛和阿片类药物的消耗。目的确定老年髋部骨折患者围手术期美沙酮的最大耐受剂量(MTD),并评估该方案在未来临床试验中的可行性。方法于2023年冬春季在医院连续收治年龄≥60岁的髋部骨折患者。采用自适应算法为每位患者分配 0.10 mg/kg、0.15 mg/kg 或 0.20 mg/kg 的美沙酮,在麻醉诱导时静脉注射。主要结果是呼吸抑制,并对其进行持续监测。如果出现呼吸抑制,则需要减少剂量;如果没有出现呼吸抑制,则需要增加剂量。骨科病房的注册护士通过术后 6、24 和 72 小时的观察表收集数据。次要结果包括在麻醉后护理病房(PACU)停留的时间、口头疼痛评分(VRS)、阿片类药物消耗量和恶心/呕吐。其中 9 人接受了 0.10 mg/kg,21 人接受了 0.15 mg/kg。三名患者在 PACU 中出现呼吸抑制,他们都接受了 0.15 mg/kg 美沙酮并进行了全身麻醉。结论 美沙酮是一种有效的髋部骨折手术镇痛药。数据表明,老年髋部骨折患者可耐受的美沙酮最大剂量为 0.10 毫克/千克。这项研究证明了我们试验设置的可行性,并为今后的随机对照试验奠定了基础。此外,研究结果表明,美沙酮的耐受性可能因麻醉方式的不同而有所差异,这值得进一步研究。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
The feasibility of perioperative methadone in older hip fracture patients: A pilot continual reassessment trial (MetaHip trial)

Background

Hip fractures cause extreme pain, primarily affecting the older and frail. The necessity of sufficient pain relief in combination with a lower tolerance for drugs makes the analgesic treatment of older patients difficult. A single dose of methadone might reduce postoperative pain and opioid consumption. However, the safety of using methadone for older and fragile patients is unknown.

Aim

Determine the maximal tolerable dose (MTD) of perioperative methadone in older hip fracture patients and assess the feasibility of this protocol for future clinical trials.

Methods

Hip fracture patients ≥60 years old were consecutively included at the hospital in the winter/spring of 2023. An adaptive algorithm allocated 0.10 mg/kg, 0.15 mg/kg, or 0.20 mg/kg of methadone to each patient, administered intravenously at the induction of anesthesia. The primary outcome was respiratory depression, which was monitored continuously. Occurrence required a dosage decrease, while absence allowed an increase. Registered Nurses at the orthopedic ward collected data using observation charts completed 6, 24, and 72 hours after surgery. Secondary outcomes include time spent in the post-anesthesia care unit (PACU), verbal rating pain score (VRS), opioid consumption, and nausea/vomiting.

Results

30 patients completed the study. Nine received 0.10 mg/kg, and 21 received 0.15 mg/kg. Three patients experienced respiratory depression in PACU, all receiving 0.15 mg/kg methadone and undergoing general anesthesia. None of the spinal anesthesia patients or those receiving 0.10 mg/kg experienced respiratory depression.

Conclusion

Methadone is an effective analgesic for hip fracture surgery. The data suggests that the maximal tolerable dose of methadone in older hip fracture patients is 0.10 mg/kg. This study proves the feasibility of our trial setup and provides a foundation for future randomized controlled trials. Additionally, the findings suggest that the tolerability of methadone may vary depending on the type of anesthesia used, which merits further investigation.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信